vs
Side-by-side financial comparison of EGAIN Corp (EGAN) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $23.0M, roughly 1.4× EGAIN Corp). EGAIN Corp runs the higher net margin — 10.2% vs -28.1%, a 38.2% gap on every dollar of revenue. On growth, EGAIN Corp posted the faster year-over-year revenue change (2.6% vs -18.9%). EGAIN Corp produced more free cash flow last quarter ($9.9M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 1.4%).
Headquartered in Sunnyvale, California, eGain Corporation helps businesses automate customer and employee experience with its AI knowledge software.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
EGAN vs RXST — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.0M | $32.6M |
| Net Profit | $2.3M | $-9.2M |
| Gross Margin | 73.1% | 77.5% |
| Operating Margin | 8.9% | -34.8% |
| Net Margin | 10.2% | -28.1% |
| Revenue YoY | 2.6% | -18.9% |
| Net Profit YoY | 248.1% | -54.1% |
| EPS (diluted) | $0.08 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.0M | $32.6M | ||
| Q3 25 | $23.5M | $30.3M | ||
| Q2 25 | $23.2M | $33.6M | ||
| Q1 25 | $21.0M | $37.9M | ||
| Q4 24 | $22.4M | $40.2M | ||
| Q3 24 | $21.8M | $35.3M | ||
| Q2 24 | $22.5M | $34.9M | ||
| Q1 24 | $22.4M | $29.5M |
| Q4 25 | $2.3M | $-9.2M | ||
| Q3 25 | $2.8M | $-9.8M | ||
| Q2 25 | $30.9M | $-11.8M | ||
| Q1 25 | $66.0K | $-8.2M | ||
| Q4 24 | $671.0K | $-5.9M | ||
| Q3 24 | $652.0K | $-6.3M | ||
| Q2 24 | $1.5M | $-6.1M | ||
| Q1 24 | $1.5M | $-9.1M |
| Q4 25 | 73.1% | 77.5% | ||
| Q3 25 | 75.2% | 79.9% | ||
| Q2 25 | 72.7% | 74.9% | ||
| Q1 25 | 68.0% | 74.8% | ||
| Q4 24 | 70.2% | 71.6% | ||
| Q3 24 | 69.4% | 71.4% | ||
| Q2 24 | 69.3% | 69.5% | ||
| Q1 24 | 69.3% | 70.1% |
| Q4 25 | 8.9% | -34.8% | ||
| Q3 25 | 12.1% | -40.1% | ||
| Q2 25 | 14.0% | -41.6% | ||
| Q1 25 | 0.1% | -28.2% | ||
| Q4 24 | 2.9% | -21.5% | ||
| Q3 24 | 2.3% | -26.1% | ||
| Q2 24 | 5.3% | -23.9% | ||
| Q1 24 | 4.2% | -36.2% |
| Q4 25 | 10.2% | -28.1% | ||
| Q3 25 | 12.0% | -32.4% | ||
| Q2 25 | 132.8% | -35.0% | ||
| Q1 25 | 0.3% | -21.6% | ||
| Q4 24 | 3.0% | -14.8% | ||
| Q3 24 | 3.0% | -17.9% | ||
| Q2 24 | 6.7% | -17.4% | ||
| Q1 24 | 6.7% | -30.8% |
| Q4 25 | $0.08 | $-0.22 | ||
| Q3 25 | $0.10 | $-0.24 | ||
| Q2 25 | $1.09 | $-0.29 | ||
| Q1 25 | $0.00 | $-0.20 | ||
| Q4 24 | $0.02 | $-0.14 | ||
| Q3 24 | $0.02 | $-0.16 | ||
| Q2 24 | $0.05 | $-0.16 | ||
| Q1 24 | $0.05 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.1M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.8M | $275.7M |
| Total Assets | $146.8M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.1M | $228.1M | ||
| Q3 25 | $70.9M | $227.5M | ||
| Q2 25 | $62.9M | $227.5M | ||
| Q1 25 | $68.7M | $229.3M | ||
| Q4 24 | $70.5M | $237.2M | ||
| Q3 24 | $67.2M | $237.1M | ||
| Q2 24 | $70.0M | $233.3M | ||
| Q1 24 | $83.0M | $125.4M |
| Q4 25 | $88.8M | $275.7M | ||
| Q3 25 | $83.5M | $276.0M | ||
| Q2 25 | $80.7M | $278.0M | ||
| Q1 25 | $51.6M | $279.3M | ||
| Q4 24 | $55.3M | $281.2M | ||
| Q3 24 | $55.7M | $277.3M | ||
| Q2 24 | $58.5M | $275.2M | ||
| Q1 24 | $63.9M | $163.9M |
| Q4 25 | $146.8M | $311.8M | ||
| Q3 25 | $144.6M | $308.5M | ||
| Q2 25 | $148.0M | $309.0M | ||
| Q1 25 | $106.2M | $313.0M | ||
| Q4 24 | $111.3M | $318.6M | ||
| Q3 24 | $114.9M | $310.5M | ||
| Q2 24 | $127.9M | $305.5M | ||
| Q1 24 | $120.3M | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.1M | $-1.1M |
| Free Cash FlowOCF − Capex | $9.9M | $-2.3M |
| FCF MarginFCF / Revenue | 43.0% | -6.9% |
| Capex IntensityCapex / Revenue | 1.0% | 3.5% |
| Cash ConversionOCF / Net Profit | 4.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.6M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.1M | $-1.1M | ||
| Q3 25 | $10.4M | $-1.2M | ||
| Q2 25 | $-4.3M | $-4.4M | ||
| Q1 25 | $2.2M | $-8.8M | ||
| Q4 24 | $6.4M | $-4.3M | ||
| Q3 24 | $954.0K | $650.0K | ||
| Q2 24 | $-5.1M | $-4.0M | ||
| Q1 24 | $1.7M | $-9.3M |
| Q4 25 | $9.9M | $-2.3M | ||
| Q3 25 | $10.2M | $-1.8M | ||
| Q2 25 | $-4.5M | $-5.9M | ||
| Q1 25 | $2.1M | $-9.4M | ||
| Q4 24 | $6.3M | $-5.1M | ||
| Q3 24 | $845.0K | $-453.0K | ||
| Q2 24 | $-5.2M | $-5.5M | ||
| Q1 24 | $1.7M | $-11.3M |
| Q4 25 | 43.0% | -6.9% | ||
| Q3 25 | 43.4% | -5.8% | ||
| Q2 25 | -19.5% | -17.6% | ||
| Q1 25 | 10.0% | -24.8% | ||
| Q4 24 | 28.1% | -12.7% | ||
| Q3 24 | 3.9% | -1.3% | ||
| Q2 24 | -23.0% | -15.9% | ||
| Q1 24 | 7.8% | -38.2% |
| Q4 25 | 1.0% | 3.5% | ||
| Q3 25 | 1.0% | 1.9% | ||
| Q2 25 | 0.9% | 4.6% | ||
| Q1 25 | 0.5% | 1.5% | ||
| Q4 24 | 0.6% | 2.1% | ||
| Q3 24 | 0.5% | 3.1% | ||
| Q2 24 | 0.2% | 4.4% | ||
| Q1 24 | 0.1% | 6.7% |
| Q4 25 | 4.33× | — | ||
| Q3 25 | 3.70× | — | ||
| Q2 25 | -0.14× | — | ||
| Q1 25 | 33.48× | — | ||
| Q4 24 | 9.57× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -3.40× | — | ||
| Q1 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGAN
| Transferred Over Time | $22.0M | 96% |
| Technology Service | $1.2M | 5% |
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
